Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells
- PMID: 2501445
- PMCID: PMC2189368
- DOI: 10.1084/jem.170.1.27
Exacerbation of murine listeriosis by a monoclonal antibody specific for the type 3 complement receptor of myelomonocytic cells. Absence of monocytes at infective foci allows Listeria to multiply in nonphagocytic cells
Abstract
Treatment of mice with a rat mAb (5C6) specific for an epitope of the type 3 complement receptor of myelomonocytic cells severely interfered with the ability of the mice to resist infection with Listeria monocytogenes. Consequently, a sublethal infection was rapidly converted to a lethal one that resulted in death in 5 d. However, infection was only exacerbated if 5C6 was given earlier in infection, before mononuclear phagocytes populated sites of Listeria implantation in the liver and spleen. If given after day 3 of infection, 5C6 caused only a temporary increase in bacterial multiplication. The infection-enhancing effect of 5C6 was associated with failure of mice to focus mononuclear phagocytes at sites of bacterial multiplication of Listeria in liver hepatocytes and extracellulary in the spleen. This resulted in unrestricted multiplication of Listeria in hepatocytes and extracellularly in the spleen. The results are in keeping with the ability of 5C6 to inhibit the accumulation of myelomonocytic cells in peritoneal inflammatory exudates, as revealed by a previous study.
Similar articles
-
Monoclonal antibody NIMP-R10 directed against the CD11b chain of the type 3 complement receptor can substitute for monoclonal antibody 5C6 to exacerbate listeriosis by preventing the focusing of myelomonocytic cells at infectious foci in the liver.J Leukoc Biol. 1992 Jul;52(1):130-2. doi: 10.1002/jlb.52.1.130. J Leukoc Biol. 1992. PMID: 1640170
-
Neutrophil-mediated dissolution of infected host cells as a defense strategy against a facultative intracellular bacterium.J Exp Med. 1991 Sep 1;174(3):741-4. doi: 10.1084/jem.174.3.741. J Exp Med. 1991. PMID: 1908513 Free PMC article.
-
Early pathogenesis of infection in the liver with the facultative intracellular bacteria Listeria monocytogenes, Francisella tularensis, and Salmonella typhimurium involves lysis of infected hepatocytes by leukocytes.Infect Immun. 1992 Dec;60(12):5164-71. doi: 10.1128/iai.60.12.5164-5171.1992. Infect Immun. 1992. PMID: 1452350 Free PMC article.
-
Monocyte-mediated immune defense against murine Listeria monocytogenes infection.Adv Immunol. 2012;113:119-34. doi: 10.1016/B978-0-12-394590-7.00003-8. Adv Immunol. 2012. PMID: 22244581 Free PMC article. Review.
-
Alteration of non-specific resistance to infection with Listeria monocytogenes.Infection. 1988;16 Suppl 2:S112-7. doi: 10.1007/BF01639732. Infection. 1988. PMID: 3138182 Review.
Cited by
-
Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection.Immunobiology. 2016 Dec;221(12):1407-1417. doi: 10.1016/j.imbio.2016.07.004. Epub 2016 Jul 16. Immunobiology. 2016. PMID: 27476791 Free PMC article. Review.
-
Intravenous injection of interferon-gamma inhibits the proliferation of Listeria monocytogenes in the liver but not in the spleen and peritoneal cavity.Immunology. 1992 Nov;77(3):354-61. Immunology. 1992. PMID: 1478682 Free PMC article.
-
Restricted replication of Listeria monocytogenes in a gamma interferon-activated murine hepatocyte line.Infect Immun. 1995 Aug;63(8):3187-95. doi: 10.1128/iai.63.8.3187-3195.1995. Infect Immun. 1995. PMID: 7542640 Free PMC article.
-
Internalin B promotes the replication of Listeria monocytogenes in mouse hepatocytes.Infect Immun. 1997 Dec;65(12):5137-41. doi: 10.1128/iai.65.12.5137-5141.1997. Infect Immun. 1997. PMID: 9393807 Free PMC article.
-
Intracellular killing of Listeria monocytogenes in the J774.1 macrophage-like cell line and the lipopolysaccharide (LPS)-resistant mutant LPS1916 cell line defective in the generation of reactive oxygen intermediates after LPS treatment.Infect Immun. 1995 May;63(5):1876-86. doi: 10.1128/iai.63.5.1876-1886.1995. Infect Immun. 1995. PMID: 7729897 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical